Back to results
US 2003/0158249 A1Published application
Use of docetaxel for treating hepatoma
AssigneeAventis Pharma S.A.
InventorsChin-Wen Chi, Heng-Liang Lin, Tsung-Yun Liu, Wing-Yiu Lui, Gar-Yang Chau
Life of this patent
Estimating the term…
Abstract
The present invention is based on the finding that docetaxel is significantly more active against hepatocellular carcinoma cells than paclitaxel at concentrations of up to 1 μM. It accordingly provides the use of docetaxel, or a hydrate thereof, in the manufacture of a medicament for use in the treatment of hepatocellular carcinoma.
Claims5
A composition for use in the treatment of hepatocellular carcinoma comprising, as active ingredient, docetaxel or a hydrate thereof.
Dependencies are inferred from the claim text.